Search - tctmd.com

Displaying 101 - 120 of 138

Sort: Relevancy | Date

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

July 03, 2014

Presentation

PREVAIL: Prospective Randomized Evaluation of the Watchman LAA Closure Device in Patients with A-fib vs Long-term Warfarin Therapy

Presenter: David R. Holmes Jr.

June 30, 2014

News Conference News ACC 2014

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

L.A. McKeown

March 31, 2014

Presentation TCT 2013

Is the Society-Driven Registry Model a Partial Solution? The TVT Registry Case Study

Presenter: David Holmes Jr

October 30, 2013

News Conference News TCT 2013

TCT Leadership Outlines the State of Intervention

October 30, 2013

News Conference News TCT 2013

Experts Discuss Efficacy, Safety of Watchman Device

October 28, 2013

Presentation TCT 2013

Left Atrial Appendage Occlusion: Results and Future Predictions

Presenter: David Holmes Jr

October 27, 2013

News Opinion Conversations in Cardiology

Conversations in Cardiology: Door-to-Balloon Time

August 19, 2013

News Conference News ACC 2013

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

L.A. McKeown

March 09, 2013

Presentation ACC 2013

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

Presenter: David R. Holmes, Jr.

March 08, 2013

News Conference News ACC 2013

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

Yael L. Maxwell

March 08, 2013

News Daily News

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

Jason Kahn

February 28, 2013

News Daily News

PROTECT AF: El Dispositivo Watchman Mejora la Calidad de Vida de Pacientes con Fibrilación Auricular

Jason Kahn

February 28, 2013

News Conference News TCT 2012

TVT Registry Sparks Discussion on Device Evaluation, Treatment Comparisons

October 26, 2012

Presentation TCT 2012

Part 2: Will the Transcatheter Valve Therapy Registry Transform US Regulatory Strategies?

Presenter: David Holmes Jr

October 25, 2012

News Conference News TCT 2012

POSEIDON: Sliding-Scale Hydration Successfully Prevents Contrast-Induced Nephropathy

October 25, 2012

News Conference News TCT 2012

Novel Devices Provide Options for LAA Therapy

October 25, 2012

Presentation TCT 2012

Long-term Results from PROTECT AF: Is the Risk-Benefit Ratio Really Uncertain?

Presenter: David Holmes Jr

October 23, 2012

News Conference News ESC 2012

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Caitlin E. Cox

August 29, 2012

Advertisement

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

PREVAIL: Prospective Randomized Evaluation of the Watchman LAA Closure Device in Patients with A-fib vs Long-term Warfarin Therapy

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

Is the Society-Driven Registry Model a Partial Solution? The TVT Registry Case Study

TCT Leadership Outlines the State of Intervention

Experts Discuss Efficacy, Safety of Watchman Device

Left Atrial Appendage Occlusion: Results and Future Predictions

Conversations in Cardiology: Door-to-Balloon Time

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

PROTECT AF: El Dispositivo Watchman Mejora la Calidad de Vida de Pacientes con Fibrilación Auricular

TVT Registry Sparks Discussion on Device Evaluation, Treatment Comparisons

Part 2: Will the Transcatheter Valve Therapy Registry Transform US Regulatory Strategies?

POSEIDON: Sliding-Scale Hydration Successfully Prevents Contrast-Induced Nephropathy

Novel Devices Provide Options for LAA Therapy

Long-term Results from PROTECT AF: Is the Risk-Benefit Ratio Really Uncertain?

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content